Last reviewed · How we verify

NCT05804851

Skin Microbiome of Chinese Population Cohort Study

Active, enrolled Last updated 6 October 2025
What this trial tests

trial in Skin Microbiome in 237 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
8 May 2023
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorWestlake University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment237
Start date8 May 2023
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across China

Conditions studied

Sponsor

Westlake University

Who can join

10 and older, any sex, with Skin Microbiome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study aims to investigate the relationship between public health and the skin microbiome in the province of Zhejiang. Due to the lack of current research on the skin microbiome, the following general questions will be investigated in this study: 1) What connection exists between dietary practices and facial skin microbiome? 2) How do people's lifestyle routines affect the facial skin microbiome? 3) What effects does the altered living environment have on people's facial skin microbiomes? 4) How do the seasons affect people's facial skin microbiomes? Every 3 to 4 months, the participants' facial skin microbiota samples will be taken, and they will be asked to complete a survey.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Skin Microbiome

Currently open trials in the same condition.

Other Westlake University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05804851.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing